Seeking people with COVID-19 Symptoms- Free COVID-19 rapid test available
Protocol: STUDY00004561
Full Title
A pilot placebo-controlled randomized double-blind trial of Melatonin in outpatients with COVID infection.
Description
This study enrolls people with COVID-19 symptoms and a positive test result for COVID-19 (a free COVID-19 rapid antigen test is available for eligible participants). These symptoms include fever, chills, cough, nasal symptoms, body aches/muscle aches, headache, loss of smell, loss of taste, nausea, vomiting, diarrhea, fatigue, dizziness. The purpose of the study is to learn if a supplement will reduce inflammation and improve immune response in people with COVID-19.

People enrolled in this study will be randomly assigned (like the flip of a coin) to take either the study supplement or a placebo. The placebo is a supplement with no active ingredients. You and the study team will not know if you are taking the study supplement or the placebo. You will take the study supplement or placebo three times a day for 14 days. Temperature, saliva samples and COVID-19 symptoms will be reported to the study team over 28-days. The study takes place entirely in your home- you will be mailed the study supplement or placebo and you will complete phone calls with the study team.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
Adults ages 18+.
Females may not be pregnant at the time of enrollment.
Must have symptoms of COVID-19 and a positive test result.
Age Group: Adults
Principal Investigator: MARGARITA DUBOCOVICH
Contact(s)
SANJAY SETHI
ssethi@buffalo.edu
+1 716-834-9200
Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.

Your information will be shared only with the research study team for recruitment purposes and designated CTSI personnel for project quality assurance and will remain confidential. Your information will be stored indefinitely. Should you no longer want this information to be provided in the aforementioned ways, please contact ctsiresearch@buffalo.edu.